Thomas Eric Duncan is in critical butstable condition. The U.S.'s largest city is now receiving doses of an experimental anti-viral drug as he fights Ebola. US Ebola patient Thomas Eric Duncan is now receiving doses of an experimental anti-viral drug as his body fought Ebola. US Ebola